Physician profile
Mark Edelstein
NPI 1437684446
$1,515.74
in general payments reported to CMS, 2019-2025
8 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $363 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Okami Medical, INC. | $695.56 | 2025 | Lobo |
| Penumbra, INC. | $296.82 | 2024-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $238.85 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $123.26 | 2024-2025 | Cryoablation Needles, Embold Fibered |
| Stryker Corporation | $82.18 | 2025 | Flowtriever, Inthrill Thrombectomy Catheter |
| W. L. Gore & Associates, INC. | $44.28 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Bard Peripheral Vascular, INC. | $19.72 | 2024 | Covera |
| Sirtex Medical INC | $15.07 | 2024 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Edelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.